United States - English - NLM (National Library of Medicine)

patrin pharma - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the prevention and treatment of portal-systemic encephalopathy, including the stages of hepatic pre-coma and coma. controlled studies have shown that lactulose solution therapy reduces the blood ammonia levels by 25 to 50%; this is generally paralleled by an improvement in the patients' mental state and by an improvement in eeg patterns. the clinical response has been observed in about 75% of patients, which is at least as satisfactory as that resulting from neomycin therapy. an increase in patients' protein tolerance is also frequently observed with lactulose therapy. in the treatment of chronic portal-systemic encephalopathy, lactulose has been given for over 2 years in controlled studies. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.

United States - English - NLM (National Library of Medicine)

unit dose services - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml

United States - English - NLM (National Library of Medicine)

foxland pharmaceuticals, inc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose for oral solution is indicated for the treatment of constipation. in patients with a history of chronic constipation, lactulose therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose for oral solution contains galactose (less than 0.3 g/10 g as a total sum with lactose), it is contraindicated in patients who require a low galactose diet.

Malta - English - Medicines Authority

cherubino limited - lactulose - oral solution - lactulose 3.35 gram(s)/5 millilitres - drugs for constipation

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - lactulose - oral solution - lactulose 670 mg/ml - drugs for constipation

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - lactulose - oral solution - lactulose 3.35 g/ml - drugs for constipation

Malta - English - Medicines Authority

central procurement & supplies unit - lactulose - oral solution - lactulose 3.35 gram(s)/5 millilitres - drugs for constipation

United States - English - NLM (National Library of Medicine)

chartwell rx, llc. - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose is a synthetic disaccharide in solution form for oral administration. each 15 ml of lactulose solution contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose, and 1.2 g or less of other sugars). also contains water. the ph range is 2.5 to 6.5. lactulose is a colonic acidifier which promotes laxation. the chemical name for lactulose is 4-o-β-d-galactopyranosyl-d-fructofuranose. the molecular formula is c 12 h 22 o 11 . it has the following structural formula: the molecular weight is 342.30. it is freely soluble in water.